ImaRx Therapeutics Reports Fourth Quarter and Year Ended 2008 Financial Results

Published: Mar 09, 2009

REDMOND, Wash., March 6, 2009 (GLOBE NEWSWIRE) -- ImaRx Therapeutics, Inc. (OTCBB:IMRX), a biopharmaceutical company focused on the development of new treatments for vascular disorders leveraging its proprietary microsphere and ultrasound technology, today reported financial results for the quarter and year ended December 31, 2008.

Back to news